Nifedipine Extended-Release Tablets have an estimated market size of US $56 million for twelve months ending September 2022
The proceeds from this fund-raise will be deployed in financing the project requirements of the API business
Acquisition expands Merck’s growing hematology portfolio
The company offers a wide portfolio of services including integrated doctor-led prescription e-commerce enablement, digital health record management, and smart clinics.
The company had responded to the agency and carried out the required corrective actions.
The approval further strengthens the Potassium Chloride franchise for the company.
The company has reported total income of Rs. 44.37 crores during the period ended September 30, 2022
The product is expected to be launched by Q4 FY23.
Strand’s new offering will help people better understand and manage diseases through genomic sequencing
Zydus becomes the only Indian oncology player to venture into prognosis and diagnosis along with treatment planning
Subscribe To Our Newsletter & Stay Updated
